Upgrade to SI Premium - Free Trial

Bristol-Myers/Celgene Deal Likely Kicks Off 'Big Year' In Biopharma M&A - RBC

January 3, 2019 3:59 PM
RBC Capital analyst Brian Abrahams said today's Bristol-Myers Squibb (NYSE: BMY) takeover of Celgene (NASDAQ: CELG) likely kicks off a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Rumors Trader Talk

Next Articles